SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000886163-16-000245
Filing Date
2016-11-14
Accepted
2016-11-14 19:12:35
Documents
58
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q lgnd-9301610q.htm 10-Q 1166317
2 EXHIBIT 10.1 dircompex101.htm EX-10.1 32907
3 EXHIBIT 31.1 lgnd_93016exhibit311.htm EX-31.1 16495
4 EXHIBIT 31.2 lgnd_93016exhibit312.htm EX-31.2 16392
5 EXHIBIT 32.1 lgnd_93016exhibit321.htm EX-32.1 15627
  Complete submission text file 0000886163-16-000245.txt   7304636

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lgnd-20160930.xml EX-101.INS 1580110
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20160930.xsd EX-101.SCH 46920
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lgnd-20160930_cal.xml EX-101.CAL 94172
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lgnd-20160930_def.xml EX-101.DEF 313396
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20160930_lab.xml EX-101.LAB 779944
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20160930_pre.xml EX-101.PRE 438631
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33093 | Film No.: 161997334
SIC: 2834 Pharmaceutical Preparations